High Gross MarginA high gross margin indicates efficient production and pricing strategies, providing a buffer against operational inefficiencies and supporting potential profitability improvements.

Manageable LeverageLow leverage enhances financial flexibility, allowing the company to navigate through challenging periods without excessive debt burdens, supporting long-term stability.

Improved Cash Burn RateAn improved cash burn rate suggests better cost management and operational efficiency, which can extend the company's runway and reduce the need for external financing.

Bears Say

Declining RevenueContinued revenue decline limits scale and operating leverage, challenging the company's ability to cover fixed costs and invest in growth, impacting long-term viability.

Persistent Large LossesOngoing large losses indicate that expenses significantly exceed revenues, which can erode equity and limit the company's ability to invest in future growth opportunities.

Negative Cash FlowNegative cash flow suggests the company is not generating sufficient cash from operations to sustain itself, increasing reliance on external funding and posing a risk to long-term sustainability.

NanoCarrier Co., Ltd. News

NANO MRNA Advances RUNX1 mRNA Clinical Trial for Osteoarthritis

The latest announcement is out from NanoCarrier Co., Ltd. ( ($JP:4571) ). NANO MRNA Co., Ltd., through its...

5M ago

NanoCarrier Advances mRNA Therapy for Osteoarthritis

NanoCarrier Co., Ltd. ( ($JP:4571) ) has provided an update. NanoCarrier Co., Ltd., through its subsidiary NANO MRNA...

7M ago

3NQ FAQ

What was NanoCarrier Co., Ltd.’s price range in the past 12 months?

NanoCarrier Co., Ltd. lowest stock price was €0.66 and its highest was €1.15 in the past 12 months.

What is NanoCarrier Co., Ltd.’s market cap?

NanoCarrier Co., Ltd.’s market cap is €57.75M.

When is NanoCarrier Co., Ltd.’s upcoming earnings report date?

NanoCarrier Co., Ltd.’s upcoming earnings report date is May 20, 2026 which is in 92 days.

How were NanoCarrier Co., Ltd.’s earnings last quarter?

NanoCarrier Co., Ltd. released its earnings results on Feb 13, 2026. The company reported -€0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.016.

Is NanoCarrier Co., Ltd. overvalued?

According to Wall Street analysts NanoCarrier Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NanoCarrier Co., Ltd. pay dividends?

NanoCarrier Co., Ltd. does not currently pay dividends.

What is NanoCarrier Co., Ltd.’s EPS estimate?

NanoCarrier Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NanoCarrier Co., Ltd. have?

NanoCarrier Co., Ltd. has 75,374,160 shares outstanding.

What happened to NanoCarrier Co., Ltd.’s price movement after its last earnings report?

NanoCarrier Co., Ltd. reported an EPS of -€0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.614%.

Which hedge fund is a major shareholder of NanoCarrier Co., Ltd.?

Currently, no hedge funds are holding shares in DE:3NQ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NanoCarrier Co., Ltd.

NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.